Advances in biomarkers and techniques for pancreatic cancer diagnosis

Cancer Cell Int. 2022 Jun 28;22(1):220. doi: 10.1186/s12935-022-02640-9.

Abstract

Pancreatic cancer is the most lethal type of malignancy and is characterized by high invasiveness without severe symptoms. It is difficult to detect PC at an early stage because of the low diagnostic accuracy of existing routine methods, such as abdominal ultrasound, CT, MRI, and endoscopic ultrasound (EUS). Therefore, it is of value to develop new diagnostic techniques for early detection with high accuracy. In this review, we aim to highlight research progress on novel biomarkers, artificial intelligence, and nanomaterial applications on the diagnostic accuracy of pancreatic cancer.

Keywords: Artificial intelligence; Biomarkers; Diagnosis; Nanomaterials; Pancreatic cancer.

Publication types

  • Review